Do you have a history of kidney stones and current risk factors for nonalcoholic fatty liver disease (NAFLD) such as obesity or diabetes?

If so, consider joining the 255-102 study, a NAFLD and Hyperoxaluria clinical trial for people with nonalcoholic fatty liver disease, investigating a new potential treatment. Study participation helps impact progression in NAFLD and Hyperoxaluria research.